Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2008-05-20
2008-05-20
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S724000, C560S125000, C560S126000, C560S128000
Reexamination Certificate
active
07375135
ABSTRACT:
The invention concerns novel molecules, their preparation and their uses, in particular in the field of human and veterinary medicine and cosmetics. The inventive compounds are partly fatty acid derivatives and exhibit advantageous pharmacological and cosmetic properties. The invention also concerns various uses of said compounds, the pharmaceutical compositions containing them and methods for preparing them. The inventive compounds are useful in particular for preventing and/or treating dyslipidemiae, cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, certain cancers, dermatological diseases and in cosmetics, for fighting against skin aging and its effects notably against wrinkles and the like.
REFERENCES:
patent: 2010154 (1935-08-01), Hubacher
patent: 4134770 (1979-01-01), Emoto et al.
patent: 5093365 (1992-03-01), Berg
patent: 5885595 (1999-03-01), Corey et al.
patent: 6117904 (2000-09-01), Murphy et al.
patent: 2006/0035977 (2006-02-01), Najib
patent: 2006/0069156 (2006-03-01), Darteil
patent: 2006/0105987 (2006-05-01), Miller
patent: 2006/0154984 (2006-07-01), Darteil
patent: 2006/0252827 (2006-11-01), Darteil
patent: 20 28 240 (1970-12-01), None
patent: 0 018 342 (1980-10-01), None
patent: 0 447 553 (1991-09-01), None
patent: 2000-169443 (2000-06-01), None
patent: 99/10321 (1990-03-01), None
patent: 97/03663 (1997-02-01), None
patent: 03/014073 (2003-02-01), None
Gouw et al., 1967, CAS:67:12802.
Grundland, 1950, CAS: 44:29936.
Isa et al., 1989, CAS: 111:201395.
Joly et al., 1938, CAS:32 :13997.
Rabinowitz et al., 1963, CAS :59 :16669.
Jart, 1962, CAS : 56 :36082.
Uehara et al., 1986, CAS :105 :196991.
Imai et al., 1998, CAS : 129 :113540.
Or Livesey et al., 1988, CAS : 109 :109267.
Database CAPLUS ′Online; Chemical Abstracts Service, Columbus, Ohio, US; Retrieved from STN, Database Accession No. 1983:18071, XP002203065.
L.P. Molleyres et al; J. Biol. Chem., vol. 263, No. 29, 1988, pp. 14832-14838, XP001042275.
K. Larsson; Acta Crystallogr.; vol. 16, 1963, pp. 741-748, XP000926795.
R. Li et al; J. Org. Chem., vol. 58, No. 7, 1993, pp. 1952-1954, XP002203063.
Chemical Abstracts, vol. 51, No. 13, Jul. 10, 1957, Columbus, Ohio, US; Abstract No. 9489f, XP002203064.
Database CAPLUS Online; Chemical Abstracts Service, Columbus, Ohio, US; Retrieved from STN, Database Accession No. 1976:151548, XP002203066.
T. Naalsund et al; Chemistry and Physics of Lipids, vol. 112, No. 1, 2001, pp. 59-65, XP000926796.
U. Heimann et al; Liebigs Ann. Chem., vol. 6, 1980, pp. 858-862, XP001042276.
File History of U.S. Appl. No. 10/504,482 obtained from U.S. PTO IFW on Jun. 22, 2007.
File History of U.S. Appl. No. 10/541,225 obtained from U.S. PTO IFW on Jun. 22, 2007.
File History of U.S. Appl. No. 10/542,056 obtained from U.S. PTO IFW on Jun. 22, 2007.
File History of U.S. Appl. No. 10/542,512 obtained from U.S. PTO IFW on Jun. 22, 2007.
International Search Report (French) for PCT/FR2004/000320 dated Oct. 5, 2004.
International Search Report of PCT/FR2004/000229, mailed Jul. 27, 2004.
Houte et al., Synthesis of structured lipids and etherlipids with antioxidants: combination of a selena fatty acid and a selena fatty alcohol with a carotenoic acid in glyceride molecules,Chemistry and Physics of Lipids, vol. 105, No. 1, 2000, pp. 105-113, XP002255207.
Naalsund et al., Synthesis of a triantioxidant compound: combination of β-apo-8′-carotenoic acid, selenacapryloic acid and trolox in a triglyceride,Chemistry and Physics of Lipids, vol. 112, 2001, pp. 59-65, XP000926796.
Database Biosis ′Online! Biosciences Information Service, Jun. 2001, Calabrese et al., Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity, XP002255209.
Calabrese et al., Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity,Neurochemical Research, vol. 26, No. 6, 2001, pp. 739-764, XP009017939.
Markesbery et al., Oxidative Alterations in Alzheimer's Disease,Brain Pathology, vol. 9, No. 1, Jan. 1999, pp. 133-146, XP009007904.
Combs et al., Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor α,Neurochemistry International, vol. 39, 2001, pp. 449-457, XP002255208.
International Search Report of PCT/FR2004/000319, mailed Aug. 10, 2004.
Database WPI, Section Ch, Week 200036, Derwent Publications Ltd., AN 2000-328909, XP0002257696.
M.D. Rahman et al., “Effects of sulphur-containing analogues of stearic acid on growth and fatty acid biosynthesis in the protozoan crithidia-fasciculata”, Journal of Medicinal Chemistry, vol. 31, No. 8, Aug. 1988, pp. 1656-1659, XP002257466, American Chemical Society.
Witten et al, Cancer, vol. 15, pp. 1041-1055, 1962.
Caumont-Bertrand Karine
Najib-Fruchart Jamila
Genfit
Nixon & Vanderhye P.C.
Shiao Rei-tsang
LandOfFree
Fatty acid derivatives; preparation and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fatty acid derivatives; preparation and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fatty acid derivatives; preparation and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2805823